Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revision Previous revision
Next revision Both sides next revision
publication:juan [2019/05/29 19:30]
游文萱
publication:juan [2019/05/29 19:30]
游文萱
Line 2: Line 2:
  
 ===== Journal Papers / 期刊論文 ===== ===== Journal Papers / 期刊論文 =====
-  - Huang, C.-T., Hsieh, C.-H., Chung, Y.-H., Oyang, Y.-J., Huang, H.-C.*, __**Juan, H.-F.**__* (2019) "​Perturbational gene-expression signatures for combinatorial drug discovery"​ iScience ​(//**Cell Press**//, doi: 10.1016/​j.isci.2019.04.039).+  - Huang, C.-T., Hsieh, C.-H., Chung, Y.-H., Oyang, Y.-J., Huang, H.-C.*, __**Juan, H.-F.**__* (2019) "​Perturbational gene-expression signatures for combinatorial drug discovery" ​//iScience// ​(**Cell Press**, doi: 10.1016/​j.isci.2019.04.039).
   - Huang, C.-T., Hsieh, C.-H., Lee, W.-C., Liu, Y.-L., Yang, T.-S., Hsu, W.-M., Oyang, Y.-J., Huang, H.-C.*, __**Juan, H.-F.**__* "​Therapeutic targeting of non-oncogene dependencies in high-risk neuroblastoma"​ //Clinical Cancer Research// (Accepted).   - Huang, C.-T., Hsieh, C.-H., Lee, W.-C., Liu, Y.-L., Yang, T.-S., Hsu, W.-M., Oyang, Y.-J., Huang, H.-C.*, __**Juan, H.-F.**__* "​Therapeutic targeting of non-oncogene dependencies in high-risk neuroblastoma"​ //Clinical Cancer Research// (Accepted).
   - Yang, T.-W., Sahu, D., Chang, Y.-W., Hsu, C.-L., Hsieh, C.-H., Huang, H.-C.*, __**Juan, H.-F.**__* (2019) “RNA-binding proteomics reveals MATR3 interacting with lncRNA SNHG1 to enhance neuroblastoma progression” //Journal of Proteome Research// 18: 406–416.   - Yang, T.-W., Sahu, D., Chang, Y.-W., Hsu, C.-L., Hsieh, C.-H., Huang, H.-C.*, __**Juan, H.-F.**__* (2019) “RNA-binding proteomics reveals MATR3 interacting with lncRNA SNHG1 to enhance neuroblastoma progression” //Journal of Proteome Research// 18: 406–416.